3Derm Systems
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Angel | ||
N/A | Seed | ||
$50.0k | Grant | ||
N/A | $680k | Debt | |
$1.2m | Debt | ||
$1.7m | Series A | ||
N/A | - | ||
$230k | Grant | ||
N/A | Acquisition | ||
Total Funding | AUD3.1m |
Related Content
Recent News about 3Derm Systems
Edit3Derm is a healthcare technology company specializing in teledermatology solutions. The company operates in the medical imaging and artificial intelligence (AI) sectors, focusing on providing dermatology access through advanced imaging systems and AI diagnostics. Its core product, the proprietary skin imaging system, captures high-quality images of skin conditions, which are then analyzed by machine learning algorithms to diagnose skin diseases with high accuracy. The company serves healthcare providers and patients, enabling remote diagnosis and treatment of skin conditions. 3Derm's business model includes selling its imaging systems and AI diagnostic services to medical institutions, generating revenue through product sales and service subscriptions. The company has received FDA Breakthrough Device designations for its autonomous skin cancer AI, highlighting its innovative approach in the healthcare market.
Keywords: teledermatology, AI diagnostics, skin imaging, healthcare technology, remote diagnosis, machine learning, FDA Breakthrough, medical imaging, dermatology access, proprietary system.